307 related articles for article (PubMed ID: 28935106)
1. Chemoenzymatic Glycan Remodeling of Natural and Recombinant Glycoproteins.
Yang Q; Wang LX
Methods Enzymol; 2017; 597():265-281. PubMed ID: 28935106
[TBL] [Abstract][Full Text] [Related]
2. Chemoenzymatic Glyco-engineering of Monoclonal Antibodies.
Giddens JP; Wang LX
Methods Mol Biol; 2015; 1321():375-87. PubMed ID: 26082235
[TBL] [Abstract][Full Text] [Related]
3. Glycan Remodeling of Human Erythropoietin (EPO) Through Combined Mammalian Cell Engineering and Chemoenzymatic Transglycosylation.
Yang Q; An Y; Zhu S; Zhang R; Loke CM; Cipollo JF; Wang LX
ACS Chem Biol; 2017 Jun; 12(6):1665-1673. PubMed ID: 28452462
[TBL] [Abstract][Full Text] [Related]
4. Chemoenzymatic Defucosylation of Therapeutic Antibodies for Enhanced Effector Functions Using Bacterial α-Fucosidases.
Li C; Li T; Wang LX
Methods Mol Biol; 2018; 1827():367-380. PubMed ID: 30196507
[TBL] [Abstract][Full Text] [Related]
5. Glycoengineered Monoclonal Antibodies with Homogeneous Glycan (M3, G0, G2, and A2) Using a Chemoenzymatic Approach Have Different Affinities for FcγRIIIa and Variable Antibody-Dependent Cellular Cytotoxicity Activities.
Kurogochi M; Mori M; Osumi K; Tojino M; Sugawara S; Takashima S; Hirose Y; Tsukimura W; Mizuno M; Amano J; Matsuda A; Tomita M; Takayanagi A; Shoda S; Shirai T
PLoS One; 2015; 10(7):e0132848. PubMed ID: 26200113
[TBL] [Abstract][Full Text] [Related]
6. Glycosynthase Mutants of Endoglycosidase S2 Show Potent Transglycosylation Activity and Remarkably Relaxed Substrate Specificity for Antibody Glycosylation Remodeling.
Li T; Tong X; Yang Q; Giddens JP; Wang LX
J Biol Chem; 2016 Aug; 291(32):16508-18. PubMed ID: 27288408
[TBL] [Abstract][Full Text] [Related]
7. Generation of a Mutant Mucor hiemalis Endoglycosidase That Acts on Core-fucosylated N-Glycans.
Katoh T; Katayama T; Tomabechi Y; Nishikawa Y; Kumada J; Matsuzaki Y; Yamamoto K
J Biol Chem; 2016 Oct; 291(44):23305-23317. PubMed ID: 27629418
[TBL] [Abstract][Full Text] [Related]
8. Site-selective chemoenzymatic glycoengineering of Fab and Fc glycans of a therapeutic antibody.
Giddens JP; Lomino JV; DiLillo DJ; Ravetch JV; Wang LX
Proc Natl Acad Sci U S A; 2018 Nov; 115(47):12023-12027. PubMed ID: 30397147
[TBL] [Abstract][Full Text] [Related]
9. Transglycosidase-like activity of Mucor hiemalis endoglycosidase mutants enabling the synthesis of glycoconjugates using a natural glycan donor.
Sakaguchi K; Katoh T; Yamamoto K
Biotechnol Appl Biochem; 2016 Nov; 63(6):812-819. PubMed ID: 26381157
[TBL] [Abstract][Full Text] [Related]
10. Glycoengineering of antibody (Herceptin) through yeast expression and in vitro enzymatic glycosylation.
Liu CP; Tsai TI; Cheng T; Shivatare VS; Wu CY; Wu CY; Wong CH
Proc Natl Acad Sci U S A; 2018 Jan; 115(4):720-725. PubMed ID: 29311294
[TBL] [Abstract][Full Text] [Related]
11. Glycosynthases enable a highly efficient chemoenzymatic synthesis of N-glycoproteins carrying intact natural N-glycans.
Huang W; Li C; Li B; Umekawa M; Yamamoto K; Zhang X; Wang LX
J Am Chem Soc; 2009 Feb; 131(6):2214-23. PubMed ID: 19199609
[TBL] [Abstract][Full Text] [Related]
12. Generation and Comparative Kinetic Analysis of New Glycosynthase Mutants from Streptococcus pyogenes Endoglycosidases for Antibody Glycoengineering.
Tong X; Li T; Li C; Wang LX
Biochemistry; 2018 Sep; 57(35):5239-5246. PubMed ID: 30102520
[TBL] [Abstract][Full Text] [Related]
13. Site-specific immobilization of endoglycosidases for streamlined chemoenzymatic glycan remodeling of antibodies.
Li T; Li C; Quan DN; Bentley WE; Wang LX
Carbohydr Res; 2018 Mar; 458-459():77-84. PubMed ID: 29475193
[TBL] [Abstract][Full Text] [Related]
14. Introducing N-glycans into natural products through a chemoenzymatic approach.
Huang W; Ochiai H; Zhang X; Wang LX
Carbohydr Res; 2008 Nov; 343(17):2903-13. PubMed ID: 18805520
[TBL] [Abstract][Full Text] [Related]
15. One-pot enzymatic glycan remodeling of a therapeutic monoclonal antibody by endoglycosidase S (Endo-S) from Streptococcus pyogenes.
Tong X; Li T; Orwenyo J; Toonstra C; Wang LX
Bioorg Med Chem; 2018 Apr; 26(7):1347-1355. PubMed ID: 28789910
[TBL] [Abstract][Full Text] [Related]
16. Chemoenzymatic synthesis of glycopeptides and glycoproteins through endoglycosidase-catalyzed transglycosylation.
Wang LX
Carbohydr Res; 2008 Jul; 343(10-11):1509-22. PubMed ID: 18405887
[TBL] [Abstract][Full Text] [Related]
17. Chemoenzymatic Methods for the Synthesis of Glycoproteins.
Li C; Wang LX
Chem Rev; 2018 Sep; 118(17):8359-8413. PubMed ID: 30141327
[TBL] [Abstract][Full Text] [Related]
18. Enzymatic deglycosylation of glycoproteins.
Kim MS; Leahy D
Methods Enzymol; 2013; 533():259-63. PubMed ID: 24182931
[TBL] [Abstract][Full Text] [Related]
19. Endo-F3 Glycosynthase Mutants Enable Chemoenzymatic Synthesis of Core-fucosylated Triantennary Complex Type Glycopeptides and Glycoproteins.
Giddens JP; Lomino JV; Amin MN; Wang LX
J Biol Chem; 2016 Apr; 291(17):9356-70. PubMed ID: 26966183
[TBL] [Abstract][Full Text] [Related]
20. Mutants of Mucor hiemalis endo-beta-N-acetylglucosaminidase show enhanced transglycosylation and glycosynthase-like activities.
Umekawa M; Huang W; Li B; Fujita K; Ashida H; Wang LX; Yamamoto K
J Biol Chem; 2008 Feb; 283(8):4469-79. PubMed ID: 18096701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
